Clindamycin Phosphate
NDC 73473-302, clindamycin phosphate, gel, from Solaris Pharma Corporation.
- Product NDC
- 73473-302
- Status
- Listed
- Labeler
- Solaris Pharma Corporation
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212842
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73473-302 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLINDAMYCIN PHOSPHATE1 g/10mL
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Lincosamide Antibacterial [EPC]; Lincosamides [CS]; Neuromuscular Blockade [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73473-302-75 | 73473030275 | 1 BOTTLE in 1 CARTON (73473-302-75) / 75 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fde07866-b012-47ad-932e-b76f141f86eeNADAC price for package 73473030275
GET /v1/drugs/nadac/73473030275
Use it
Look up 73473-302 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73473-302 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73473-302. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.